Hudkræftklinikken.dk ApS: Financial statements 2022
CVR: 38219960
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Hudkræftklinikken.dk ApS (CVR 38219960) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,291,638 and a net result of DKK -363,008 compared with DKK 557,379 the year before. That is a decrease of 26.9% compared with the year before. Equity in the 2022 report amounted to DKK 1,168,572. The solvency ratio was 50.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,291,638
- Profit/Loss
- DKK -363,008
- Equity
- DKK 1,168,572
- Total Assets
- DKK 2,304,947
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.3M | -363K | 1.2M | 2 |
| 2021 | - | 1.8M | 557K | 2.6M | 2 |
| 2020 | - | 1.7M | 167K | 2.4M | - |
| 2019 | - | 2.1M | -819K | 2.2M | - |
| 2018 | - | 1.6M | 58K | 3.3M | - |
Official annual report
Keep an eye on Hudkræftklinikken.dk ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 3, 2022, Inanna Pia Weiss has left the board of directors of Hudkræftklinikken.dk ApS.
Hudkræftklinikken.dk ApS has published its annual report for 2021. Gross profit came to DKK 1,767,284, and the net result was DKK 557,379.
About Hudkræftklinikken.dk ApS
Hudkræftklinikken.dk ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Speciallægers aktiviteter. The company was previously named Hudkræftklinikken.dk Anpartsselskab. The management consists of Bolette Birch Bengtsen. The board consists of Robert Birger Birch (chair), Kent Stevens Larsen and Martin Glud. The company's owners include Birch Bengtsen Invest ApS, PHOENIX CAPITAL ApS and M.Glud holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 1,898,097 and a net result of DKK -210,331 compared with DKK 9,266 the year before. Equity in the 2025 report amounted to DKK 757,000.